While a slow but steady rise in Covid-19 vaccine availability and vaccination has offered a light at the end of the tunnel, the challenges that come with ending the pandemic seem to be endless. Most recently, the US Centers for Disease Control and Prevention and the US Food and Drug Administration recommended pausing Johnson & Johnson's vaccine due to six reported cases of a severe type of blood clot.